Milena A Ozimek,
Lab Administration Coordinator 1
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0002-4998-1167
Publications
2024
Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare
Pharmaceutics.
16(3)
[DOI] 10.3390/pharmaceutics16030332.
[PMID] 38543226.
2024
Exploring the impact of CYP2D6 and UGT2B7 gene-drug interactions, and CYP-mediated DDI on oxycodone and oxymorphone pharmacokinetics using physiologically-based pharmacokinetic modeling and simulation
European Journal of Pharmaceutical Sciences.
194
[DOI] 10.1016/j.ejps.2023.106689.
2024
Interspecies Brain PBPK Modeling Platform to Predict Passive Transport through the Blood–Brain Barrier and Assess Target Site Disposition
Pharmaceutics.
16(2)
[DOI] 10.3390/pharmaceutics16020226.
[PMID] 38399280.
2024
Pharmacokinetic and Pharmacodynamic Analysis of Acetaminophen and Ibuprofen Dual Therapy for Patent Ductus Arteriosus Closure in Preterm Neonates at Less Than 29 Weeks of Gestation
The Journal of Clinical Pharmacology.
64(3):312-322
[DOI] 10.1002/jcph.2386.
2023
PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris
CPT: Pharmacometrics & Systems Pharmacology.
12(6):770-782
[DOI] 10.1002/psp4.12949.
[PMID] 36915233.
2023
Barriers to global pharmacometrics: educational challenges and opportunities across the globe
CPT: Pharmacometrics & Systems Pharmacology.
12(6):743-747
[DOI] 10.1002/psp4.12940.
[PMID] 36960632.
2023
Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug–Drug Interactions of Phenytoin
Pharmaceutics.
15(10)
[DOI] 10.3390/pharmaceutics15102486.
[PMID] 37896246.
2023
Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies
CPT: Pharmacometrics & Systems Pharmacology.
12(7):1016-1028
[DOI] 10.1002/psp4.12973.
[PMID] 37186151.
2023
Exploring Trends in Social Vulnerability for Pharmacy Students at a Large Public University.
American journal of pharmaceutical education.
87(12)
[DOI] 10.1016/j.ajpe.2023.100551.
[PMID] 37336326.
2023
Informing a Comprehensive Risk Assessment of Infant Drug Exposure From Human Milk: Application of a Physiologically Based Pharmacokinetic Lactation Model for Sotalol
The Journal of Clinical Pharmacology.
63(S1)
[DOI] 10.1002/jcph.2242.
2023
Leveraging Physiologically Based Modelling to Provide Insights on the Absorption of Paliperidone Extended-Release Formulation under Fed and Fasting Conditions
Pharmaceutics.
15(2)
[DOI] 10.3390/pharmaceutics15020629.
[PMID] 36839950.
2023
Model-Based Analysis of In Vivo Release Data of Levonorgestrel Implants: Projecting Long-Term Systemic Exposure
Pharmaceutics.
15(5)
[DOI] 10.3390/pharmaceutics15051393.
[PMID] 37242635.
2023
Requirements, expectations, challenges and opportunities associated with training the next generation of pharmacometricians
CPT: Pharmacometrics & Systems Pharmacology.
12(7):883-888
[DOI] 10.1002/psp4.12970.
[PMID] 37452453.
2023
The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies
CPT: Pharmacometrics & Systems Pharmacology.
12(5):639-655
[DOI] 10.1002/psp4.12927.
[PMID] 36752286.
2022
Application of exposure bracketing to streamline the development of contraceptive products
Contraception: X.
4
[DOI] 10.1016/j.conx.2022.100072.
[PMID] 35243326.
2022
Development of a model‐based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy
CPT: Pharmacometrics & Systems Pharmacology.
11(3):318-332
[DOI] 10.1002/psp4.12753.
[PMID] 34877803.
2022
Development of a Translational Exposure‐Bracketing Approach to Streamline the Development of Hormonal Contraceptive Drug Products
Clinical Pharmacology & Therapeutics.
112(4):909-916
[DOI] 10.1002/cpt.2690.
2022
Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid
International Journal of Antimicrobial Agents.
59(2)
[DOI] 10.1016/j.ijantimicag.2021.106509.
2020
Pharmacokinetics of tedizolid, sutezolid, and sutezolid-M1 in non-human primates
European Journal of Pharmaceutical Sciences.
151
[DOI] 10.1016/j.ejps.2020.105421.
2020
Population Pharmacokinetic Modeling of Acetaminophen Protein Adducts in Adults and Children
The Journal of Clinical Pharmacology.
60(5):595-604
[DOI] 10.1002/jcph.1555.
[PMID] 31802503.
2019
Acetaminophen Protein Adducts in Hospitalized Children Receiving Multiple Doses of Acetaminophen
The Journal of Clinical Pharmacology.
59(10):1291-1299
[DOI] 10.1002/jcph.1442.
[PMID] 31099052.
Contact Details
Phones:
- Business:
- (407) 313-7050
Emails:
- Business:
- mozimek@ufl.edu
Addresses:
- Business Mailing:
-
6550 SANGER RD OFC 465
ORLANDO FL 32827 - Business Street:
-
6550 SANGER RD
ORLANDO FL 32827